Effect of Glycoprotein IIb/IIIa Antagonist Abciximab on Monocyte-Platelet Aggregates and Tissue Factor Expression

Sabine Steiner(Helmholtz Munich), Christoph Kopp(Friedrich-Alexander-Universität Erlangen-Nürnberg), Daniela Seidinger(Wilhelminen Hospital), Kurt Huber(Sigmund Freud Privatuniversität Wien), Christoph Kaun(University of Vienna), Erich Minar(Medical University of Vienna)

Arteriosclerosis Thrombosis and Vascular Biology

July 22, 2003

10.1161/01.atv.0000087035.46547.89

Cited by 46

Related Papers

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

|European Heart Journal|2012|6.8k

Balloon Angioplasty versus Implantation of Nitinol Stents in the Superficial Femoral Artery

|New England Journal of Medicine|2006|1.2k

Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation

|Circulation|2011|1.1k

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

|The Lancet|2018|793

High Plasma Levels of Factor VIII and the Risk of Recurrent Venous Thromboembolism

|New England Journal of Medicine|2000|765